TABLE OF CONTENTS
Volume 3, Issue 3 (June 2003)
Editorial
Editorial: Hidden Diamonds
Brian Smith
J Med Market 3: 172-173; doi:10.1057/palgrave.jmm.5040116
Papers
Defining, justifying and implementing the Balanced Scorecard in the National Health Service
Zoe Radnor and Bill Lovell
J Med Market 3: 174-188; doi:10.1057/palgrave.jmm.5040117
Strategic responses of pharmaceutical companies and healthcare organisations to maintain competitive advantage in the cataract market
Georgios Labiris, Georgios Papadopoulis and Andreas Petounis
J Med Market 3: 189-193; doi:10.1057/palgrave.jmm.5040118
Miscellaneous
Guest Editorial: Defending value and maximising profitability of innovative pharmaceuticals over their entire life cycles
Lindsay Bruce
J Med Market 3: 195-197; doi:10.1057/palgrave.jmm.5040119
Papers
Generic pharmaceutical cases: A review of 2002's cases and 'long arm' relief — the current position
Lindsay Bruce
J Med Market 3: 199-203; doi:10.1057/palgrave.jmm.5040120
Common mistakes that undermine patent protection and how to avoid them
Mike Hutchins
J Med Market 3: 204-211; doi:10.1057/palgrave.jmm.5040121
Using interlocking additional early stage patents to improve and extend patent protection
Mike Hutchins
J Med Market 3: 212-215; doi:10.1057/palgrave.jmm.5040122
Global patent enforcement
Nigel Stoate
J Med Market 3: 216-219; doi:10.1057/palgrave.jmm.5040123
The latest thinking on best strategies for use of supplementary certificates
Julian Hitchcock and Bülent Tugal
J Med Market 3: 220-225; doi:10.1057/palgrave.jmm.5040124
The art of using secondary patents to improve protection
Michael Burdon and Kristie Sloper
J Med Market 3: 226-238; doi:10.1057/palgrave.jmm.5040125
EU enlargement, the Bolar exemption and parallel imports: The consequences for market exclusivity
Nigel Stoate
J Med Market 3: 239-244; doi:10.1057/palgrave.jmm.5040126
Pricing policies to handle patent loss or expiry
Adam Barak and Geoffrey Wilson
J Med Market 3: 245-249; doi:10.1057/palgrave.jmm.5040127
